MedPath

Latent Tuberculosis Infection in Korean Health Care Workers

Not Applicable
Conditions
Latent Tuberculosis
Registration Number
NCT03010111
Lead Sponsor
Hanyang University
Brief Summary

The investigators aim to study the prevalence of latent tuberculosis infection (LTBI) using whole-blood interferon-r release assays, and determine the risk factors of LTBI in Korean health care workers.

Detailed Description

Further study details as provided by Hanyang University Hospital

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
240
Inclusion Criteria
  • Health care workers in University affiliated hospital
  • Adult aged 20-65
Exclusion Criteria
  • Active tuberculosis
  • Subjects diagnosed with HIV infection, malignancy
  • Subjects having immunosuppressive drug therapy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Percentage of latent tuberculosis infection developed in Korean health care workersThree months

The participants performed QuaniFERON-TB Gold In-Tube test (QFT-IT test) and blood sampling at enrollment. So, the length of time which from the start of the first test of very first participants to the end of test of very last participant is 3 months. The percentage of participants with LTBI in health care workers was evaluated.

Secondary Outcome Measures
NameTimeMethod
Annual incidence of latent tuberculosis infection in Korean health care workers1 year after first QFT-IT test (12-15 months)

QFT-IT test was performed at enrollment and repeated at point of one year after enrollment. So, the length of time which from the start of the first test of very first participants to the end of the second test of very last participant is 12 to 15 months. The percentage of participants with positive conversion in follow-up QFT-IT test (second test) was evaluated in participants who had negative results in the first QFT-IT test. Annual infection of LTBI was evaluated with the conversion of QFT-IT test through annual check up of QFT-IT test.

Trial Locations

Locations (1)

Hanyang University Hospital

🇰🇷

Seoul, Korea, Republic of

Hanyang University Hospital
🇰🇷Seoul, Korea, Republic of
Jang Won Shon, M.D., Ph.D.
Contact
82-2-2290-8351
jwsohn@hanyang.ac.kr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.